#immunotherapy — Thursday, August 27, 2026 (2 items)
| 0 | ℹ |
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.
(nature.com)
|
Nature Medicine 2026-08-27 | #immunotherapy #autoimmune #rheumatoid arthritis #clinical trial #car-t | |
| 0 | ℹ |
Combined type 2 cytokine blockade enhances PD-1-mediated antitumor immunity.
(linkinghub.elsevier.com)
|
Cell Reports 2026-08-27 | #cancer #immunotherapy #cytokine #immunity #checkpoint-inhibitors |